New Method Improves Analysis of Long-Term Treatment Effects
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
-
-
Metformin Does Not Reduce Seizures in Active Epilepsy Patients
This study looked at the effects of adding metformin, a medication commonly used for diabetes, to standard anti-seizure treatments in people with active epilepsy.
-
Mycophenolate Mofetil Reduces Relapses in NMDA Encephalitis Patients
This study looked at the effects of a medication called mycophenolate mofetil (MMF) on patients with a serious condition known as anti-NMDA receptor encephalitis (NMDARE).
-
Comparing Laser Therapy and Surgery for Drug-Resistant Epilepsy
Researchers studied two surgical treatments for people with drug-resistant epilepsy: open resective surgery (ORS) and laser interstitial thermal therapy (LITT).
-
Pyridoxine May Help Reduce Behavioral Issues in Kids on Levetiracetam
This study looked at how pyridoxine, also known as vitamin B6, might help reduce neuropsychiatric side effects caused by the epilepsy medication levetiracetam in children and adolescents.
-
Physicians Share Insights on Seizure Prediction Technology for Epilepsy
This study looked at how doctors who treat epilepsy in Malaysia view a new digital service designed to predict seizures based on heart activity.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Pediatrics | Recent Research | Safety & First Aid
Lacosamide May Help Reduce Seizures in Children with Epilepsy
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
-
MMSEc Tool Helps Identify Intellectual Disabilities in Children
This study looked at how well the Modified Mini-Mental State Examination for Children (MMSEc) can identify intellectual disabilities in children aged 6 to 14.
-
Comorbidities | Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Imaging & EEG | Recent Research
High Healthcare Costs for Patients Before Neurostimulator Implantation
This study looked at the healthcare use and costs for people with drug-resistant epilepsy (DRE) who were enrolled in Medicaid and received a neurostimulator implant.
